Is BioMarin Pharmaceutical Inc halal to invest in?

As of July 2026, BioMarin Pharmaceutical Inc BMRN is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is BioMarin Pharmaceutical Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BioMarin Pharmaceutical Inc using these criteria to determine its compliance status.

Can Muslims buy shares of BioMarin Pharmaceutical Inc?

Muslim investors may consider investing in BioMarin Pharmaceutical Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is BioMarin Pharmaceutical Inc classified as HALAL?

Musaffa determines the Shariah status of BioMarin Pharmaceutical Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for BioMarin Pharmaceutical Inc updated?

The Shariah compliance status of BioMarin Pharmaceutical Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like BioMarin Pharmaceutical Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of BioMarin Pharmaceutical Inc?

You can check the latest Shariah compliance status of BioMarin Pharmaceutical Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BMRN Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, BioMarin Pharmaceutical Inc is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

BioMarin Pharmaceutical Inc. Stock Analysis BMRN

United States Health Care Large Cap Report: Q1, 2026

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. The company is headquartered in San Rafael California, California and currently employs 3,221 full-time employees. The firm has a portfolio of commercial therapies and a clinical and preclinical pipeline. Its commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno-associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Its Galafold (migalastat) is the first oral treatment for Fabry disease, and Pombiliti (cipaglucosidase alfa-atga) + Opfolda (miglustat), is a two-component therapy for Pompe disease.

Key Statistics of BioMarin Pharmaceutical Inc (BMRN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$58.30$59.98

Today's Open

$59.50

Volume

1.18M

P/E Ratio (TTM)

32.80

52 Week Range

$49.26$66.28

Market Cap

11.55B

Avg. Volume

1.73M

Dividend Yield

Financial Metrics & Statements of BioMarin Pharmaceutical Inc (BMRN)

Super Investors Invested in BioMarin Pharmaceutical Inc (BMRN)

FAQ's for BioMarin Pharmaceutical Inc (BMRN)

As of July 2026, BioMarin Pharmaceutical Inc BMRN is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BioMarin Pharmaceutical Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in BioMarin Pharmaceutical Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of BioMarin Pharmaceutical Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of BioMarin Pharmaceutical Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of BioMarin Pharmaceutical Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.